Earnings Feed
Start Free
Home/Filings/4/0001855763-21-000015
4//SEC Filing

BUNKA CHRISTOPHER 4

Accession 0001855763-21-000015

CIK 0001348362other
View on SEC.govCompany Profile

Filed

Jun 8, 8:00 PM ET

Accepted

Jun 9, 12:48 PM ET

Size

10.3 KB

Accession

0001855763-21-000015

Insider Transaction Report

Form 4
Period: 2021-05-07
Lexaria Bioscience Corp.LEXX
BUNKA CHRISTOPHER
DirectorChariman/CEO/President/CFO
Transactions
  • Other

    Stock Options

    2021-05-07−23,334→ 32,667 total
    Exercise: $10.20From: 2020-04-23Exp: 2025-04-23→ Common Shares (23,334 underlying)
Holdings

  • Stock Options

    Exercise: $5.83From: 2021-04-26Exp: 2026-04-26→ Common Shares (26,000 underlying)
    56,001

  • common shares

    (indirect: Private Holding Company)
    215,912

  • Warrants

    (indirect: Private Holding Company)
    Exercise: $10.50From: 2020-05-06Exp: 2025-05-06→ Common Shares (6,667 underlying)
    6,667

  • common shares

    273,543

  • Stock Options

    Exercise: $10.20From: 2020-04-23Exp: 2025-04-23→ Common Shares (23,334 underlying)
    30,001
Footnotes (1)
  • [F1]Cancelled Options

Documents

1 file

Issuer

Lexaria Bioscience Corp.

CIK 0001348362

→
Entity typeother

Related Parties

1
  • filerCIK 0001103780

Filing Metadata

Form type
4
Filed
Jun 8, 8:00 PM ET
Accepted
Jun 9, 12:48 PM ET
Size
10.3 KB
View on SEC.gov